Zeltia S.A. (ZEL SM; ZEL MC) today presented its financial results for 2005 which feature a sharp increase in its investment in Research and Development, to a total of 45.7 million euros. Its subsidiary PhamaMar accounts for most of that sum (37.8 million euros).
